Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 526.2 DKK 3.58% Market Closed
Market Cap: 37.5B DKK

Intrinsic Value

The intrinsic value of one ZEAL stock under the Base Case scenario is hidden DKK. Compared to the current market price of 526.2 DKK, Zealand Pharma A/S is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZEAL Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Zealand Pharma A/S

Intrinsic Value History
Dive into the past to invest in the future

ZEAL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ZEAL usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ZEAL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ZEAL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Zealand Pharma A/S.

Explain Valuation
Compare ZEAL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ZEAL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 16.6B
Cash & Short-Term Investments 16.2B
Receivables 224.7m
Other Current Assets 226.9m
Non-Current Assets 176.2m
PP&E 141.4m
Intangibles 12.7m
Other Non-Current Assets 22.1m
Current Liabilities 1.2B
Accounts Payable 243.9m
Other Current Liabilities 934.7m
Non-Current Liabilities 456.1m
Long-Term Debt 383.9m
Other Non-Current Liabilities 72.2m
Efficiency

Free Cash Flow Analysis
Zealand Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zealand Pharma A/S

Revenue
9.2B DKK
Cost of Revenue
-1.2m DKK
Gross Profit
9.2B DKK
Operating Expenses
-1.9B DKK
Operating Income
7.3B DKK
Other Expenses
-724.1m DKK
Net Income
6.5B DKK
Fundamental Scores

ZEAL Profitability Score
Profitability Due Diligence

Zealand Pharma A/S's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional ROE
Exceptional Operating Margin
ROIC is Increasing
hidden
Profitability
Score

Zealand Pharma A/S's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ZEAL Solvency Score
Solvency Due Diligence

Zealand Pharma A/S's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Zealand Pharma A/S's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZEAL Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZEAL is 766.08 DKK with a low forecast of 404 DKK and a high forecast of 1 176 DKK.

Lowest
Price Target
404 DKK
23% Downside
Average
Price Target
766.08 DKK
46% Upside
Highest
Price Target
1 176 DKK
123% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zealand Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ZEAL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

ZEAL News

Other Videos
What is the Intrinsic Value of one ZEAL stock?

The intrinsic value of one ZEAL stock under the Base Case scenario is hidden DKK.

Is ZEAL stock undervalued or overvalued?

Compared to the current market price of 526.2 DKK, Zealand Pharma A/S is hidden .

Back to Top